This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Southern California. Active years: 2020-2025.
Company Filing History:
Years Active: 2020-2025
Title: Roberta Buono: Innovator in Cancer and Diabetes Research
Introduction
Roberta Buono is a prominent inventor based in Los Angeles, CA, known for her groundbreaking work in the fields of cancer and diabetes research. With a total of 2 patents, she has made significant contributions to medical science, particularly in developing innovative treatment methods.
Latest Patents
One of her latest patents is titled "Fasting-mimicking diet promotes cancer-free survival in acute lymphoblastic leukemia models." This patent outlines a method for treating leukemia, specifically lymphoblastic leukemia, by administering a fasting-mimicking diet (FMD) to patients, optionally in combination with chemotherapeutic agents and/or autophagy inhibitors. Another notable patent is "Drug combinations and methods to stimulate embryonic-like regeneration to treat diabetes and other diseases." This invention discusses how stem cell-based therapies can potentially reverse organ dysfunction and diseases. It highlights the challenges of removing impaired tissue and reactivating the regeneration program. In her research, a four-day fasting mimicking diet induces significant biological changes in mice, promoting insulin production and restoring glucose homeostasis in both type 1 and type 2 diabetes models.
Career Highlights
Roberta Buono is affiliated with the University of Southern California, where she continues her research and innovation in medical treatments. Her work has garnered attention for its potential to change the landscape of treatment for serious health conditions.
Collaborations
Roberta collaborates with Valter D Longo, a fellow researcher, to further explore the implications of their findings and enhance the effectiveness of their treatments.
Conclusion
Roberta Buono's contributions to cancer and diabetes research through her innovative patents demonstrate her commitment to advancing medical science. Her work has the potential to significantly impact the treatment of these diseases, offering hope for improved patient outcomes.